Product Information
PF-06291874 is a monoclonal antibody that binds to the active form of glucagon-like peptide 1 (GLP-1) and inhibits its degradation by dipeptidyl peptidase IV. PF-06291874 is orally administered and has been shown in clinical trials to significantly reduce blood glucose levels in patients with type 2 diabetes. It has also been shown to have pharmacokinetic properties that are different from other GLP-1 receptor agonists, which may allow it to be used as an antidiabetic agent for diabetic patients who cannot use other oral agents.
Chemical properties
Technical inquiry about: 3D-TFC12408 PF-06291874
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
